Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiichi Ohshima

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Proteomics|May 7, 2011
Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteomeKeiichi Hatakeyama, Keiichi Ohshima, Yorikane Fukuda, et al.
Biosensors & Bioelectronics|December 26, 2006
Detection of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) using a fully automated system with a nano-scale engineered biomagnetiteKohei Maruyama, Haruko Takeyama, Tetsushi Mori, et al.
Pharmaceutical Research|August 5, 2004
Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrilsSatomi Onoue, Keiichi Ohshima, Kazuhiro Debari, et al.
Biomedical Research (Tokyo, Japan)|December 3, 2025
Analysis of HLA class I allele genotypes and immune-related gene alterations in patients with pan-cancer using whole-exome and whole-genome sequencingAkira Iizuka, Yasuto Akiyama, Tomoatsu Ikeya, et al.
Biomedical Research (Tokyo, Japan)|February 28, 2017
Comprehensive analysis of gene mutation and expression profiles in neuroendocrine carcinomas of the stomachRie Makuuchi, Masanori Terashima, Masatoshi Kusuhara, et al.
Anticancer Research|June 9, 2016
Novel Tumor-specific Mutations in Receptor Tyrosine Kinase Subdomain IX Significantly Reduce Extracellular Signal-regulated Kinase ActivityMasakuni Serizawa, Masatoshi Kusuhara, Sumiko Ohnami, et al.
European Journal of Pharmacology|February 6, 2004
Alpha-helical structure in the C-terminus of vasoactive intestinal peptide: functional and structural consequencesSatomi Onoue, Asami Matsumoto, Yumiko Nagano, et al.
Biomedical Research (Tokyo, Japan)|March 7, 2015
Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE—Ken Yamaguchi, Kenichi Urakami, Keiichi Ohshima, et al.
Biomedical Research (Tokyo, Japan)|December 14, 2022
Consensus molecular subtyping improves the clinical usefulness of canonical tumor markers for colorectal cancerHiroyasu Kagawa, Keiichi Hatakeyama, Akio Shiomi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2020
Aberrant expression of Wnt/β-catenin signaling pathway genes in aggressive malignant gastric gastrointestinal stromal tumorsKeiichi Fujiya, Keiichi Ohshima, Yuko Kitagawa, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Proteomics|May 7, 2011
Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteomeKeiichi Hatakeyama, Keiichi Ohshima, Yorikane Fukuda, et al.
Biosensors & Bioelectronics|December 26, 2006
Detection of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) using a fully automated system with a nano-scale engineered biomagnetiteKohei Maruyama, Haruko Takeyama, Tetsushi Mori, et al.
Pharmaceutical Research|August 5, 2004
Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrilsSatomi Onoue, Keiichi Ohshima, Kazuhiro Debari, et al.
Biomedical Research (Tokyo, Japan)|December 3, 2025
Analysis of HLA class I allele genotypes and immune-related gene alterations in patients with pan-cancer using whole-exome and whole-genome sequencingAkira Iizuka, Yasuto Akiyama, Tomoatsu Ikeya, et al.
Biomedical Research (Tokyo, Japan)|February 28, 2017
Comprehensive analysis of gene mutation and expression profiles in neuroendocrine carcinomas of the stomachRie Makuuchi, Masanori Terashima, Masatoshi Kusuhara, et al.
Anticancer Research|June 9, 2016
Novel Tumor-specific Mutations in Receptor Tyrosine Kinase Subdomain IX Significantly Reduce Extracellular Signal-regulated Kinase ActivityMasakuni Serizawa, Masatoshi Kusuhara, Sumiko Ohnami, et al.
European Journal of Pharmacology|February 6, 2004
Alpha-helical structure in the C-terminus of vasoactive intestinal peptide: functional and structural consequencesSatomi Onoue, Asami Matsumoto, Yumiko Nagano, et al.
Biomedical Research (Tokyo, Japan)|March 7, 2015
Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE—Ken Yamaguchi, Kenichi Urakami, Keiichi Ohshima, et al.
Biomedical Research (Tokyo, Japan)|December 14, 2022
Consensus molecular subtyping improves the clinical usefulness of canonical tumor markers for colorectal cancerHiroyasu Kagawa, Keiichi Hatakeyama, Akio Shiomi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2020
Aberrant expression of Wnt/β-catenin signaling pathway genes in aggressive malignant gastric gastrointestinal stromal tumorsKeiichi Fujiya, Keiichi Ohshima, Yuko Kitagawa, et al.
Pageof 11